Pharmacist Management of Attention Deficit Hyperactivity Disorder Medication Refill Requests
NCT06388694 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 315
Last updated 2024-08-30
Summary
This cluster randomized trial will compare pharmacist management of secure message requests for refills of attention deficit hyperactivity medications with primary care physician management regarding quality of care, timeliness of service, and parent care experience.
Conditions
- Attention-deficit Hyperactivity
Interventions
- OTHER
-
Pharmacist Care
Pharmacists will provide ADHD medication refill orders in response to secure message requests by parents, under the authorization of appropriate physicians.
- OTHER
-
Primary Care Physician Care
Primary care pediatricians will provide ADHD medication refill orders in response to secure message requests by parents. This is usual care.
Sponsors & Collaborators
-
Kaiser Permanente
lead OTHER
Principal Investigators
-
Tracy A Lieu · Kaiser Permanente Northern California Division of Research
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-06
- Primary Completion
- 2024-06-21
- Completion
- 2024-07-31
Countries
- United States
Study Locations
More Related Trials
-
Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)
NCT03325894 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
NCT05683249 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
NCT02578030 ·Status: COMPLETED ·Phase: PHASE1
-
AWARE: Management of ADHD in Autism Spectrum Disorder
NCT05916339 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD
NCT06359899 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT01458340 ·Status: COMPLETED ·Phase: PHASE2
-
Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01238822 ·Status: COMPLETED ·Phase: PHASE4
-
Methylphenidate in Healthy Young Adults
NCT00815841 ·Status: UNKNOWN ·Phase: PHASE4
-
Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders
NCT02063945 ·Status: TERMINATED ·Phase: PHASE4
-
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
NCT06673368 ·Status: TERMINATED ·Phase: PHASE2
-
Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT00686933 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder
NCT00467428 ·Status: COMPLETED ·Phase: PHASE2
-
Web Based Tools to Improve Medication Continuity in Adolescents With ADHD
NCT04386096 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)
NCT01070394 ·Status: COMPLETED ·Phase: PHASE4
-
A Long-term Trial of EB-1020 in Adult Patients With ADHD
NCT06926829 ·Status: RECRUITING ·Phase: PHASE3
-
Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)
NCT02253745 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT03618030 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003)
NCT00610441 ·Status: COMPLETED ·Phase: PHASE2
-
The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With ADHD: A Lipidomic Study
NCT03936491 ·Status: COMPLETED ·Phase: NA
-
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
NCT03292952 ·Status: COMPLETED ·Phase: PHASE3
-
Does Active Parent Involvement in Deliberation and Choice Improve Medication Persistence for Their Child With ADHD
NCT00631280 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT04112082 ·Status: UNKNOWN ·Phase: NA
-
Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD
NCT00307268 ·Status: COMPLETED
-
A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)
NCT01174355 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity
NCT01863459 ·Status: COMPLETED ·Phase: PHASE4